复星医药(600196.SH)：膦甲酸钠注射液获注册批准

Core Viewpoint - Fosun Pharma's subsidiary, Guilin Pharmaceutical Co., has received approval from the National Medical Products Administration for the registration of sodium phosphonate injection, which is indicated for the treatment of cytomegalovirus retinitis in AIDS patients and herpes simplex virus infections in immunocompromised patients [1] Group 1 - The approved drug is sodium phosphonate injection [1] - The indications for the drug include treatment for cytomegalovirus retinitis in AIDS patients [1] - The drug is also indicated for herpes simplex virus infections in patients with immune dysfunction [1]